NPPB and coronary artery disorder: To our knowledge, this study provides the largest prospective data set on NT-proBNP levels in clinically healthy, term newborns on days 2 to 4 of life; however, the observed variation in control newborns and newborns with CHD needs further exploration to optimize timing and improve cutoff values of DBS NT-proBNP screening.